<DOC>
	<DOCNO>NCT00432523</DOCNO>
	<brief_summary>Primary objective : To compare , give concomitantly VARIVAX® route 12-18 month age use separate injection site , single dose M-M-RTMII administer IM route immunogenic single dose M-M-RTMII administer SC route term response rate measles , mumps rubella 42 day follow vaccination . AND/OR To compare , give concomitantly M-M-RTMII route 12-18 month age use separate injection site , single dose VARIVAX® administer IM route immunogenic single dose VARIVAX® administer SC route term response rate varicella 42 day follow vaccination Secondary objective : - To summarise antibody titre measles , mumps , rubella varicella 42 day follow vaccination child immunise M-M-R™II VARIVAX® administer concomitantly two separate injection site route IM SC , - To evaluate safety profile M-M-R™II VARIVAX® administer concomitantly two separate injection site route IM SC .</brief_summary>
	<brief_title>Immunogenicity Safety Concomitant Administration MMR™ rHA VARIVAX® Intramuscular Versus Subcutaneous Route</brief_title>
	<detailed_description />
	<mesh_term>Measles</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<criteria>1 . Healthy subject either gender , 2 . Age 12 18 month , 3 . Consent form sign parent ( ) legal representative properly inform study , 4 . Parent ( ) / legal representative able understand protocol requirement fill Diary Card . 1 . Prior receipt measles , mumps , rubella varicella vaccine either alone combination vaccine , 2 . Known suspected clinical history infection measles , mumps , rubella , varicella zoster , 3 . Any recent ( ≤30 day ) exposure measles , mumps rubella , 4 . Any recent ( ≤30 day ) exposure varicella zoster involve : 5 . Any recent ( ≤3 day ) history febrile illness 6 . Any severe chronic disease , 7 . Active untreated tuberculosis , 8 . Known personal history seizure , 9 . Any known blood dyscrasia , leukemia , lymphomas type , malignant neoplasm affect bone marrow lymphatic system , 10 . Any severe thrombocytopenia coagulation disorder would contraindicate intramuscular injection , 11 . Any immune impairment humoral/cellular deficiency , neoplastic disease depress 12 . Any recent tuberculin test ( ≤7 day ) schedule tuberculin test visit 2 , 13 . Any previous ( ≤150 day ) receipt immune serum globulin bloodderived product schedule administer visit 2 , 14 . Any recent receipt inactivate live vaccine ( ≤30 day ) schedule vaccination visit 2</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prevention : Measles , Mumps , Rubella Varicella disease</keyword>
</DOC>